SPDL1 and neoplasm: The role of soluble biomarkers is further enhanced when considered alongside novel markers like sPD-1/sPD-L1, which are involved in immune regulation and could add significant value to the existing biomarker panels by providing insights into immune response and tumor immune evasion mechanisms.